The Connect 360 GLP-1 Program addresses the rise in diabetes and GLP-1 spend, providing substantial savings for SmithRx employer groups, and improving access to GLP-1 therapy during the current FDA drug shortages.
Agenda Highlights:
- Overview of the GLP-1 program: Start with a broad overview of increased demand and GLP-1 spend.
- Key Program Details: FDA shortage information, GLP-1 compounding products, better understanding of how this program improves access to GLP-1 therapy and overall member experience.
- Program Participation: Member engagement and group enrollment details.
We'll end with a Q&A to give you an opportunity to address your specific questions.
Upcoming Sessions:
Tuesday, November 26th, 12:00pm PT
Thursday, December 4th, 1:00pm PT
Tuesday, December 10th, 9:00am PT
Tuesday, December 17th, 9:00am PT
Hosts
Speakers
Lisa Hyde
Manager, Customer Training, SmithRx